NINA Medical won the Seal-of-Excellence from the EIC Horizon

Feb 2025: NINA Medical Receives European Commission's Seal of Excellence for LOTUS-1 Project

January 22, 2025

News

NINA Medical Receives European Commission's Seal of Excellence for LOTUS-1 Project

We are proud to announce that our innovative project, LOTUS-1, a non-invasive diagnostic-therapeutic system for the treatment of Benign Prostatic Hyperplasia (BPH), has been awarded the prestigious Seal of Excellence from the European Commission's EIC Horizon program. This recognition follows a highly competitive evaluation by an international panel of experts, acknowledging LOTUS-1 as a high-quality, game-changing proposal.

‍

NINA Medical's delegation to the EIC Horizon finals in Brussels. Left to right: Christos Monovoukas, Chairman of the Board. Livnat Benzur, Director of Business Development and Technology, NGT Healthacre. Shmuel Ben-Ezra, Co-founder and CEO.

While the project could not receive direct funding from the EIC due to budgetary constraints, this Seal of Excellence is a powerful endorsement of our technology's potential to revolutionize BPH treatment. It serves as a quality label, recommending our project for funding by other national and private sources and solidifying our position at the forefront of medical innovation. This achievement is a testament to the hard work of our dedicated team and strengthens our commitment to bringing this transformative solution to patients worldwide.